Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A rare HIV reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine.

× No keyword cloud information.

5 in total

Review 1. HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.

Authors: Robert W Shafer; Jonathan M Schapiro
Journal: AIDS Rev Date: 2008 Apr-Jun Impact factor: 2.500

2. Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility.

Authors: George L Melikian; Soo-Yon Rhee; Jonathan Taylor; W Jeffrey Fessel; David Kaufman; William Towner; Paolo V Troia-Cancio; Andrew Zolopa; Gregory K Robbins; Ron Kagan; Dennis Israelski; Robert W Shafer
Journal: Antimicrob Agents Chemother Date: 2012-02-13 Impact factor: 5.191

3. In vitro human immunodeficiency virus type 1 resistance selections with combinations of tenofovir and emtricitabine or abacavir and lamivudine.

Authors: N A Margot; J M Waters; M D Miller
Journal: Antimicrob Agents Chemother Date: 2006-09-18 Impact factor: 5.191

4. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.

Authors: Diane E Bennett; Ricardo J Camacho; Dan Otelea; Daniel R Kuritzkes; Hervé Fleury; Mark Kiuchi; Walid Heneine; Rami Kantor; Michael R Jordan; Jonathan M Schapiro; Anne-Mieke Vandamme; Paul Sandstrom; Charles A B Boucher; David van de Vijver; Soo-Yon Rhee; Tommy F Liu; Deenan Pillay; Robert W Shafer
Journal: PLoS One Date: 2009-03-06 Impact factor: 3.240

5. Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance.

Authors: Soo-Yon Rhee; Philip L Tzou; Robert W Shafer
Journal: Viruses Date: 2021-05-11 Impact factor: 5.048

5 in total